Showing results (51-60 of 188) with videos related to

Sort By:
Pageof 19
Alimentary Pharmacology & Therapeutics|September 5, 2019
Systematic review with meta-analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseasesSiddharth Singh, Parambir S Dulai, Niels Vande Casteele, et al.
BMC Pulmonary Medicine|July 4, 2013
The health economic impact of disease management programs for COPD: a systematic literature review and meta-analysisMelinde R S Boland, Apostolos Tsiachristas, Annemarije L Kruis, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
A Living Organoid Biobank of Crohn's Disease Patients Reveals Distinct Clinical Correlates of Molecular Subtypes of DiseaseHarrison M Penrose, Saptarshi Sinha, Courtney Tindle, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 10, 2026
New Approach Methodologies in Crohn's Disease Link Molecular Disease Subtypes to Clinical OutcomesHarrison M Penrose, Saptarshi Sinha, Courtney Tindle, et al.
Alimentary Pharmacology & Therapeutics|December 11, 2024
Long-Term Outcomes of an Infliximab-First Versus Vedolizumab-First Treatment Strategy in Biologic-Naïve Patients With Ulcerative ColitisAustin Haynesworth, Kuan-Hung Yeh, Han Hee Lee, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|January 23, 2014
Are GOLD ABCD groups better associated with health status and costs than GOLD 1234 grades? A cross-sectional studyMelinde R S Boland, Apostolos Tsiachristas, Annemarije L Kruis, et al.
Nanotechnology|June 1, 2011
Transparent conducting films from NbSe3 nanowiresSukanta De, Conor S Boland, Paul J King, et al.
Inflammatory Bowel Diseases|November 25, 2020
Histologic Remission Is Associated With Lower Risk of Treatment Failure in Patients With Crohn Disease in Endoscopic RemissionHyuk Yoon, Sushrut Jangi, Parambir S Dulai, et al.
Pageof 19